Please login (Members) to view content or
(Nonmembers) this article.
No votes yet
Letters to the Editor

Letters to The Editor

Lisa Schulmeister
Peter C. Pieslor
CJON 2003, 7(1), 12 DOI: 10.1188/03.CJON.12

In a recent “Clinical Q&A” titled “Handling and Disposal of Monoclonal Antibodies,” the author reviewed guidelines for your readers (Estes, 2002). The manufacturers are not correct in Table 1 on page 290. Zevalin® is manufactured by IDEC Pharmaceuticals Corporation in San Diego, CA. Rituxan® is comarketed by IDEC Pharmaceuticals Corporation and Genentech, Inc., in South San Francisco, CA.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or